Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1976;54(2):193–198.

Type B and non-B viral hepatitis in Jerusalem*

S Gerald Sandler, Daniel Shouval Steigbuegel, Mira Marcus, Marcel Eliakim
PMCID: PMC2366428  PMID: 1088102

Abstract

In a two-year survey of adult patients hospitalized with acute viral hepatitis in Jerusalem, 27% were reactive for the hepatitis B surface antigen (HBsAg) by radioimmunoassay and therefore diagnosed as having hepatitis B. The majority of patients (73%) were non-reactive for HBsAg and their diagnosis was non-B hepatitis (“type unspecifiable”). Thirty-one per cent of patients with hepatitis B and only 5% of patients with non-B hepatitis had histories consistent with parenteral transmission of hepatitis by blood transfusion or drug use. An additional 19% of the patients with hepatitis B had possible parenteral exposure and 50% had no obvious parenteral exposure, indicating that non-parenteral transmission of the hepatitis B virus (HBV) may be a significant epidemiological factor (50-69%) in the Jerusalem area. The prominent role of non-parenteral transmission of HBV is further evidenced by the relatively high prevalences of HBsAg (0.97%) and antibody to hepatitis B surface antigen (anti-HBs) (19.0%) in healthy blood donors. These findings are consistent with the view that personal contact and intra-familial spread may be important factors in the epidemiology of HBV and indicate that non-parenterally transmitted HBV contributes significantly to endemic viral hepatitis in the Jerusalem area.

Full text

PDF
193

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter H. J., Holland P. V., Morrow A. G., Purcell R. H., Feinstone S. M., Moritsugu Y. Clinical and serological analysis of transfusion-associated hepatitis. Lancet. 1975 Nov 1;2(7940):838–841. doi: 10.1016/s0140-6736(75)90234-2. [DOI] [PubMed] [Google Scholar]
  2. Bryan J. A., Gregg M. B. Viral hepatitis in the United States, 1970-1973: an analysis of morbidity trends and the impact of HBS Ag testing on surveillance and epidemiology. Am J Med Sci. 1975 Sep-Oct;270(2):271–282. [PubMed] [Google Scholar]
  3. Cossart Y. E., Vahrman J. Studies of Australia-SH antigen in sporadic viral hepatitis in London. Br Med J. 1970 Feb 14;1(5693):403–405. doi: 10.1136/bmj.1.5693.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dietrichson O., Juhl E., Christoffersen P., Elling P., Faber V., Iversen K., Nielsen J. O., Petersen P., Poulsen H. Acute viral hepatitis: factors possibly predicting chronic liver disease. Acta Pathol Microbiol Scand A. 1975 Jan;83(1):183–188. doi: 10.1111/j.1699-0463.1975.tb01371.x. [DOI] [PubMed] [Google Scholar]
  5. Hadziyannis S. J. Nonparenteral transmission of viral hepatitis in Greece. Am J Med Sci. 1975 Sep-Oct;270(2):313–318. [PubMed] [Google Scholar]
  6. Jelić O., Cubelić P., Fiser-Herman M. Australija antigen i antitijelo u serumima bolesnika s akutnim virusnim hepatitisom, lijecenim u bolnici u Slavonskom Brodu. Acta Med Iugosl. 1973;27(2):119–128. [PubMed] [Google Scholar]
  7. Lander J. J., Alter H. J., Purcell R. H. Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. J Immunol. 1971 May;106(5):1166–1171. [PubMed] [Google Scholar]
  8. Liebermeister R. G. Hepatitis-B-Antigen bei Virushepatitis in München. Med Klin. 1974 Jul 5;69(27):1202–1207. [PubMed] [Google Scholar]
  9. Ling C. M., Overby L. R. Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody. J Immunol. 1972 Oct;109(4):834–841. [PubMed] [Google Scholar]
  10. Mosley J. W. Hepatitis types B and non-B. Epidemiologic background. JAMA. 1975 Sep 1;233(9):967–969. [PubMed] [Google Scholar]
  11. Pal S. R., Chitkara N. L., Choudhury S., Dutta D. V., Deodhar S. D., Chhuttani P. N. Hepatitis B virus infection in northern India. Prevalence, subtypes, and seasonal variation. Bull World Health Organ. 1974;51(1):13–17. [PMC free article] [PubMed] [Google Scholar]
  12. Peterson M. R., Barker L. F., Schade D. S. Detection of antibody to hepatitis-associated antigen in hemophilia patients and in voluntary blood donors. Vox Sang. 1973 Jan;24(1):66–75. doi: 10.1111/j.1423-0410.1973.tb03858.x. [DOI] [PubMed] [Google Scholar]
  13. Rachmilewitz M., Eliakim M. Serum B12--a diagnostic test in liver disease. Isr J Med Sci. 1968 Jan-Feb;4(1):47–54. [PubMed] [Google Scholar]
  14. Reisler D. M., Brachott D., Mosley J. W. Viral hepatitis in Israel: morbidity and mortality data. Am J Epidemiol. 1970 Jul;92(1):62–72. doi: 10.1093/oxfordjournals.aje.a121180. [DOI] [PubMed] [Google Scholar]
  15. Sama S. K., Anand S., Malaviya A. N., Gandhi P. C., Tandon B. N. Australia-SH antigen in normal population and patients of viral hepatitis in Delhi. Indian J Med Res. 1971 Jan;59(1):64–68. [PubMed] [Google Scholar]
  16. Sandler S. G., Shlomo A. S., Shraga S., Ever-Hadani P. High- and low-risk blood donors in Jerusalem: a survey of the hepatitis B antigen (HBsAg). Isr J Med Sci. 1975 Apr;11(4):345–351. [PubMed] [Google Scholar]
  17. Skinhoj P., Al-Kassab S. Letter: Hepatitis-B antigen in Iraq. Lancet. 1973 Dec 1;2(7840):1269–1269. doi: 10.1016/s0140-6736(73)91013-1. [DOI] [PubMed] [Google Scholar]
  18. Szmuness W., Prince A. M., Diebolt G., Leblanc L., Baylet R., Masseyeff R., Linhard J. The epidemiology of hepatitis B infections in Africa: results of a pilot survey in the Republic of Senegal. Am J Epidemiol. 1973 Aug;98(2):104–110. doi: 10.1093/oxfordjournals.aje.a121535. [DOI] [PubMed] [Google Scholar]
  19. Villarejos V. M., Serra J., Hernandez G. Endemoepidemic non-parenteral type B hepatitis in Costa Rica. Am J Med Sci. 1975 Sep-Oct;270(2):309–312. [PubMed] [Google Scholar]
  20. Villarejos V. M., Visoná K. A., Eduarte C. A., Provost P. J., Hilleman M. R. Evidence for viral hepatitis other than type A or type B among persons in Costa Rica. N Engl J Med. 1975 Dec 25;293(26):1350–1352. doi: 10.1056/NEJM197512252932606. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES